Duke Cancer

We celebrate Duke research saving lives - making stories like Spencer's possible. Dr. Nicholas DeVito leads a clinical trial of a new immunotherapy w/out any chemotherapy. Spencer's minimal side effects keep him on his feet. @DukeU | @DukeMedSchool | @DukeCancer

A team at DCI is launching a first-of-its-kind study that could bring new hope to patients living with advanced #ColorectalCancer. duke.is/w/r2hv @DukeMedSchool | @DukeSurgery | @DukeEngineering

By rethinking how and where cervical cancer diagnosis happens, Duke researchers are working to bring AI‑powered cervical imaging to clinics in Kenya and rethink how diagnosis could work everywhere. duke.is/m/buqw #CervicalCancer | @DukeMedSchool | @DukeGWHT | @DukeUBME

The newly formalized DCI Pancreatic Cancer Center focuses on improving access and methods for early detection and then developing novel clinical pathways for patients diagnosed with early-stage disease. duke.is/2/5u3w #PancreaticCancer | @DukeHealth

Collaboration at DCI helped spark Shane Killarney’s discovery about how tumors become resistant to treatment. Now he’s a resident at Brigham and Women’s, carrying DCI’s team-science spirit with him. duke.is/v/v2ts @Duke_PCB | @DukeMedSchool

Plastic is everywhere in our environment. DCI's Jason Somarelli, PhD, and Diane Reidy-Lagunes, MD, discuss plastic pollution's potential impact on cancer risk and how we can protect ourselves. Watch the full Conversations in Cancer video: duke.is/r/fw8z @DukeHealth

What’s next for radiation oncology at Duke? Dr. Erik Sulman, chair of @DukeRadOnc and interim executive director of @DukeCancer, shares his vision for innovation, training, and clinical excellence in a new conversation with Dean Mary Klotman. 📽️: youtube.com/watch?v=ch2v7g…

New guidelines from @ASTRO_org define the role of radiation therapy for #GastricCancer, providing evidence-based recommendations for care. DCI's Christopher G. Willett, MD, chaired the panel that developed these guidelines. duke.is/6/hvr5 @DukeMedSchool | @DukeRadOnc

An engineer asked how he could help fight prostate cancer — and ended up jumpstarting a breakthrough. Walt and Arlene Simmons’ stimulus awards at Duke didn’t just inspire innovation. They helped invent it. duke.is/y/tf8t #ProstateCancer | @DukeMedSchool | @DukeUBME

@MRHarrisonMD showing latest data from the Odyssey RCC registry: greater QOL with IO/IO therapy vs IO/TKI. @DukeCancer @DukeGUCancer

Great talks from our @DukeGUCancer leaders @AarmstrongDuke and @Daniel_J_George here at @ASCO #GU26 reviewing #prostatecancer trial design guidance from #PCWG4 and important PROs with #CAPItello281. Fortunate to work with each of you and the whole @DukeCancer #GUru team.

A clinical trial led by DCI members is testing a powerful new immunotherapy that unleashes the body’s own defenses to fight advanced colorectal cancer. duke.is/n/tfqt #ColorectalCancer | @TriangleBIZJrnl | @DukeHealth | @DukeMedSchool

New guidelines from @NCCN focused on pediatric soft tissue sarcomas mark a pivotal advancement in the landscape of pediatric oncology. DCI's Stephen Skapek, MD, spoke to @ScienceMagazine about this release. duke.is/m/8ekg #Sarcoma | #PediatricCancers | @DukeHealth

DCI's Michael Pignone, MD, spoke with @Yahoo about how the death of actor James Van Der Beek highlights the concerning rise of colorectal cancer cases in people under 50. duke.is/w/pksa #ColorectalCancer | @DukeHealth

DCI's Trudy Oliver, PhD, has received the Vicky Amidon Innovation in Lung Cancer Research Award from the @LC_Initiative_. Her project will investigate why certain lung cancers become resistant to chemotherapy. duke.is/w/58nu #LungCancer | @DukeMedSchool | @Duke_PCB

DCI's Nimmi Ramanujam, PhD, has been elected to the National Academy of Engineering. She is recognized for breakthroughs transforming women’s cancer care globally. duke.is/9/fvq2 #CervicalCancer | @dukeresearch | @DukeEngineering | @DukeHealth

If you have recurrent or platinum-resistant #OvarianCancer, your doctor may recommend folate receptor alpha testing. DCI's Angeles Alvarez Secord, MD, spoke to @EverydayHealth about what that testing entails. duke.is/4/yysw @DukeHealth

Results from a new clinical trial led by DCI members suggest a gene-based assay could help physicians better assess the risk of cancer spread in patients with early-stage #Melanoma and spare them from unnecessary surgery. duke.is/y/ztd6 @DukeMedSchool | @DukeSurgery

When people hear ‘vaccine,’ they think flu or pneumonia. What makes a cancer vaccine different? DCI's Diane Reidy-Lagunes, MD, and cancer vaccine researcher Zachary Hartman, PhD, discuss. Watch the full Conversations in Cancer video: duke.is/9/vsht @DukeHealth

Researchers from DCI and @DukeMedSchool have discovered a new vulnerability that appears during the brief moments when cancer cells switch states, as well as a way to exploit this weakness, opening a potential new path for cancer treatment. duke.is/y/ezd9 @Duke_PCB